| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT07500090 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic… |
Trial sites expanded: 22 -> 40 locations |
| 2026-08-13 | NCT07675135 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy |
Trial sites expanded: 14 -> 50 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06366464 | A Study of Pitolisant in Patients With Prader-Willi Syndrome | Prader-Willi Syndrome | Recruiting |
| NCT07675135 | A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy | EDS | Recruiting |
| NCT07500090 | A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic… | Idiopathic Hypersomnia | Recruiting |
| NCT07219485 | A Study of Pitolisant in Participants With Prader-Willi Syndrome | Prader-Willi Syndrome | Enrolling by Invitation |
| Not specified | |||
| NCT05536011 | WAKIX® (Pitolisant) Pregnancy Registry | Pregnancy Related | Recruiting |